Registry for heart support devices after severe circulation problems
Part of Heart & circulation clinical trials.
This study is a registry that collects information from adults who need a temporary heart circulation support device such as VA-ECMO or an Impella pump (or newer similar devices). It may help doctors better understand which patients benefit most and how these devices are used in real life.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be over 18 years old.
- Your doctors must plan to implant a peripheral VA-ECMO or an Impella-type pump (or a newer similar device).
- You (or a legally allowed family member/relative) must be able to sign consent, unless consent is waived by the study rules.
- This study does not list any other exclusion conditions.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This registry collects information from patients admitted to the hospital with cardiogenic shock—a serious condition where the heart cannot pump enough blood to the body. Doctors will gather data to better understand what happens to these patients and how to improve their care.
This registry collects information about people who are placed on ECMO, a heart-lung machine used to support breathing and/or circulation. It may help doctors better understand who benefits and how to manage ECMO in the future.
This trial tests a device that helps support your heart when it's in cardiogenic shock (a life-threatening condition where the heart can't pump enough blood). The device works alongside standard treatments to improve blood flow and reduce strain on the heart.
This trial tests a new heart pump device (CorVad) to support the heart in people who are in cardiogenic shock after a heart attack. It may help stabilize blood pressure and improve blood flow, potentially giving the heart time to recover.
This registry collects information about people who have cardiogenic shock, a serious condition where the heart cannot pump enough blood. Your participation may help doctors learn which treatments and monitoring best improve outcomes.
This study will look at whether “left ventricular unloading” (using a device like IABP or Impella) helps people who are in cardiogenic shock while on VA ECMO. It compares outcomes for people who get unloading versus those who stay on VA ECMO alone.
Hear when a new Cardiogenic Shock trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.